| P50 | author | Lesley A Colvin | Q56438406 |
| | Marie Fallon | Q64220832 |
| P2093 | author name string | Ada Delaney | |
| | Rory Mitchell | |
| | Susan M Fleetwood-Walker | |
| | Marie T Fallon | |
| | Robert G Dalziel | |
| P2860 | cites work | The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia | Q49022334 |
| | The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale | Q49049732 |
| | A prognostic score for postherpetic neuralgia in ambulatory patients. | Q50851498 |
| | The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. | Q51487570 |
| | The Use of Oral Mexiletine for the Treatment of Pain after Peripheral Nerve Injury | Q51694351 |
| | Clinical and psychosocial correlates of post-herpetic neuralgia. | Q51872376 |
| | Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom | Q56768031 |
| | Allodynia in rats infected with varicella zoster virus—a small animal model for post-herpetic neuralgia | Q59853775 |
| | Capsaicin evoked pain and allodynia in post-herpetic neuralgia | Q60684292 |
| | Postherpetic neuralgia | Q67341370 |
| | Further studies on galanin-, substance P-, and CGRP-like immunoreactivities in primary sensory neurons and spinal cord: effects of dorsal rhizotomies and sciatic nerve lesions | Q67686338 |
| | Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation | Q69808015 |
| | Mechanical allodynia in postherpetic neuralgia: evidence for central mechanisms depending on nociceptive C-fiber degeneration | Q70850767 |
| | Population-based study of herpes zoster and its sequelae | Q72112939 |
| | Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve | Q72744329 |
| | The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain | Q73328419 |
| | Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury | Q73445277 |
| | Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms | Q73555393 |
| | Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia | Q74182809 |
| | Pain and somatosensory dysfunction in acute herpes zoster | Q77925426 |
| | Pregabalin: in the treatment of postherpetic neuralgia | Q81174005 |
| | Analgesic therapy in postherpetic neuralgia: a quantitative systematic review | Q21144723 |
| | Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society | Q24657295 |
| | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 |
| | Recommendations for the Management of Herpes Zoster | Q28315869 |
| | Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial | Q29029237 |
| | Neuronal plasticity: increasing the gain in pain | Q29615421 |
| | The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation | Q30759388 |
| | Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. | Q31076606 |
| | Phase specific analysis of herpes zoster associated pain data: a new statistical approach | Q31955443 |
| | EFNS guidelines on neuropathic pain assessment | Q33199137 |
| | Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin | Q33213049 |
| | Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study | Q33379728 |
| | Neuropathic pain: aetiology, symptoms, mechanisms, and management | Q33661273 |
| | A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain | Q33679477 |
| | Transcriptional and posttranslational plasticity and the generation of inflammatory pain | Q33679553 |
| | The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons | Q33735104 |
| | Postherpetic neuralgia: role of gabapentin and other treatment modalities | Q33756731 |
| | Prospects for the prevention of postherpetic neuralgia in herpes zoster patients | Q33952426 |
| | The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia | Q33989760 |
| | Gabapentin in pain management | Q34014600 |
| | Sodium channels and the molecular pathophysiology of pain | Q34093984 |
| | Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain | Q34116102 |
| | Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain | Q34132344 |
| | Treatment and prevention of postherpetic neuralgia | Q34185543 |
| | Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial | Q34213412 |
| | Antidepressants in the treatment of neuropathic pain | Q34420689 |
| | The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial | Q34430826 |
| | Postherpetic neuralgia: irritable nociceptors and deafferentation | Q34483000 |
| | Epidemiology and treatment of neuropathic pain: the UK primary care perspective | Q34503159 |
| | Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis | Q34561157 |
| | EFNS guidelines on pharmacological treatment of neuropathic pain. | Q34573607 |
| | An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy | Q34590272 |
| | Sodium channel blockade may contribute to the analgesic efficacy of antidepressants | Q34592159 |
| | Pharmacologic management of neuropathic pain: evidence-based recommendations | Q34699259 |
| | A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster | Q34727198 |
| | Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group | Q34733837 |
| | Herpes zoster (shingles) and postherpetic neuralgia | Q34954600 |
| | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo | Q34977329 |
| | Translation of symptoms and signs into mechanisms in neuropathic pain | Q35079363 |
| | Ketamine in chronic pain management: an evidence-based review | Q35591383 |
| | Varicella zoster virus latency, neurological disease and experimental models: an update | Q35650933 |
| | Comorbidities in chronic neuropathic pain | Q35680402 |
| | Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia | Q35752866 |
| | The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. | Q35824087 |
| | Natural history of pain following herpes zoster | Q35866913 |
| | The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles | Q36656146 |
| | Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? | Q36761156 |
| | Somatosensory findings in postherpetic neuralgia | Q36933847 |
| | Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia. | Q37039254 |
| | Natural history and treatment of herpes zoster | Q37048021 |
| | An update on the treatment of postherpetic neuralgia | Q37048029 |
| | Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia | Q37048037 |
| | The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine | Q37141163 |
| | Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs | Q38603800 |
| | NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study | Q39312497 |
| | Effect of pulsed radiofrequency for postherpetic neuralgia | Q39313532 |
| | Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief | Q39316888 |
| | Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study | Q39388670 |
| | Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials | Q39407750 |
| | Peripheral neuropathic pain--a multidimensional burden for patients | Q39412303 |
| | Intrathecal methylprednisolone for intractable postherpetic neuralgia | Q39424571 |
| | Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study | Q39438845 |
| | Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia | Q39447109 |
| | A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia | Q39494085 |
| | Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia | Q39508711 |
| | A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia | Q39520536 |
| | Messenger plasticity in primary sensory neurons following axotomy and its functional implications | Q40387628 |
| | Pain and its persistence in herpes zoster | Q40924528 |
| | Sodium channel expression: a dynamic process in neurons and non-neuronal cells | Q40956751 |
| | Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia | Q42117334 |
| | Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study | Q42644229 |
| | Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts | Q43161154 |
| | Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia. | Q43568384 |
| | Acute pain in herpes zoster: the famciclovir database project | Q43750649 |
| | Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study | Q43787190 |
| | Intercostal nerve block with 5% tetracaine for chronic pain syndromes | Q43906558 |
| | Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia | Q44027119 |
| | Clinical applications for change-point analysis of herpes zoster pain | Q44030202 |
| | The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles | Q44038120 |
| | Pharmacological characterisation of the spared nerve injury model of neuropathic pain | Q44050833 |
| | Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception | Q44106429 |
| | Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. | Q44220892 |
| | A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain | Q44264315 |
| | Gabapentin Blocks and Reverses Antinociceptive Morphine Tolerance in the Rat Paw-pressure and Tail-flick Tests | Q44419213 |
| | Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels | Q44783790 |
| | Painful neuropathy alters the effect of gabapentin on sensory neuron excitability in rats | Q44802265 |
| | Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. | Q44843017 |
| | Risk factors for postherpetic neuralgia in patients with herpes zoster | Q44891234 |
| | Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs | Q45423431 |
| | An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia | Q45849093 |
| | Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. | Q46192578 |
| | Cutaneous innervation density in the allodynic form of postherpetic neuralgia | Q46232843 |
| | Postherpetic neuralgia--fighting pain with fire | Q46270001 |
| | Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. | Q48704575 |
| | Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury | Q48724675 |
| | Postherpetic neuralgia in immunocompetent elderly people | Q48786475 |
| | Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. | Q48796677 |
| P433 | issue | 4 | |
| P304 | page(s) | 630-637 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Neurotherapeutics | Q15716631 |
| P1476 | title | Postherpetic neuralgia: from preclinical models to the clinic | |
| P478 | volume | 6 | |